Literature DB >> 7510115

Establishment of new ovarian and colon carcinoma cell lines: differentiation is only possible by cytokeratin analysis.

V J Möbus1, R Moll, C D Gerharz, D G Kieback, W Weikel, G Hoffmann, R Kreienberg.   

Abstract

Two human ovarian (OV-MZ-10, OV-MZ-15) and two colon cancer cell lines (CO-MZ-5, CO-MZ-6) were newly established in permanent cell culture. These cell lines have been maintained in vitro for 5-6 years, the passage number varying from 25 to 228. They were established from ascites or solid tumours at the time of primary surgery. By clinical and histopathological judgement alone all four cell lines would have been interpreted as ovarian cancer cell lines. Morphological criteria or the expression of the tumour-associated antigens CA-125 and CEA allowed no differential diagnosis. Only the analysis of the expression of different cytokeratins and vimentin enabled us to verify the different origin of the cell lines. Ovarian cancer cell lines, in contrast to the colon cancer cell lines, are positive for the expression of cytokeratin (CK) 7 and for vimentin. CK 20 proved to be the marker with the best discrimination. CK 20 was found exclusively in the colon carcinoma cell lines, but not in the ovarian carcinoma cell lines. The evaluation of cytokeratin expression is a helpful diagnostic modality in differentiating between adenocarcinoma cell lines derived from ovarian and colon tumours.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7510115      PMCID: PMC1968867          DOI: 10.1038/bjc.1994.78

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  Immunohistochemical demonstration of keratin 7 in routinely fixed paraffin-embedded human tissues.

Authors:  C C van Niekerk; P H Jap; F C Ramaekers; F van de Molengraft; L G Poels
Journal:  J Pathol       Date:  1991-10       Impact factor: 7.996

2.  Differential diagnosis of gastrointestinal carcinomas by using monoclonal antibodies specific for individual keratin polypeptides.

Authors:  M Osborn; G van Lessen; K Weber; G Klöppel; M Altmannsberger
Journal:  Lab Invest       Date:  1986-10       Impact factor: 5.662

Review 3.  The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells.

Authors:  R Moll; W W Franke; D L Schiller; B Geiger; R Krepler
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

4.  Human colon adenocarcinoma cells. III. In vitro organoid expression and carcinoembryonic antigen kinetics in hollow fiber culture.

Authors:  L P Rutzky; J T Tomita; M A Calenoff; B D Kahan
Journal:  J Natl Cancer Inst       Date:  1979-10       Impact factor: 13.506

5.  Complexity of expression of intermediate filament proteins, including glial filament protein, in endometrial and ovarian adenocarcinomas.

Authors:  R Moll; S Pitz; R Levy; W Weikel; W W Franke; B Czernobilsky
Journal:  Hum Pathol       Date:  1991-10       Impact factor: 3.466

6.  Subcellular distribution, synthesis, and release of carcinoembryonic antigen in cultured human colon adenocarcinoma cell lines.

Authors:  Z R Shi; D Tsao; Y S Kim
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

7.  Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.

Authors:  R Moll; A Löwe; J Laufer; W W Franke
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

8.  Complex cytokeratin polypeptide patterns observed in certain human carcinomas.

Authors:  R Moll; R Krepler; W W Franke
Journal:  Differentiation       Date:  1983       Impact factor: 3.880

9.  Acidic and basic hair/nail ("hard") keratins: their colocalization in upper cortical and cuticle cells of the human hair follicle and their relationship to "soft" keratins.

Authors:  M H Lynch; W M O'Guin; C Hardy; L Mak; T T Sun
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

10.  Establishment and characterisation of three new human ovarian carcinoma cell lines and initial evaluation of their potential in experimental chemotherapy studies.

Authors:  B T Hill; R D Whelan; E M Gibby; D Sheer; L K Hosking; S A Shellard; H T Rupniak
Journal:  Int J Cancer       Date:  1987-02-15       Impact factor: 7.396

View more
  3 in total

1.  Development and evaluation of peptidic ligands targeting tumour-associated urokinase plasminogen activator receptor (uPAR) for use in alpha-emitter therapy for disseminated ovarian cancer.

Authors:  Sebastian Knör; Sumito Sato; Timo Huber; Alfred Morgenstern; Frank Bruchertseifer; Manfred Schmitt; Horst Kessler; Reingard Senekowitsch-Schmidtke; Viktor Magdolen; Christof Seidl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-22       Impact factor: 9.236

2.  Establishment and characterization of a human colon cancer cell line, OUMS-23, from a patient with familial adenomatous polyposis.

Authors:  M Miyazaki; S Tsuboi; K Mihara; T Kosaka; K Fukaya; K Kino; M Mori; M Namba
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

3.  Complexity of expression of the intermediate filaments of six new human ovarian carcinoma cell lines: new expression of cytokeratin 20.

Authors:  T Yanagibashi; I Gorai; T Nakazawa; E Miyagi; F Hirahara; H Kitamura; H Minaguchi
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.